Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14247)	7/27/2000 10:37:40 PM
From: Robert K.	Respond to of 17367

Cacaito, >your comment."Rk, the master of mixing all improbable stuff, , you even concocted the egregious idea that bpi was used in the zovant trials, and worse that the placebo group in trauma trial got huge amounts of bpi via blood transfusion. Just couple of posts back you even reverse the zovant vs trauma trials subject numbers. You just forgot to inform xoma of your findings so they can save the company" My comment, wrong, wrong and wrong again. You are twisting my words, therefore your comments are twisted. Just like you said cacaito>"bpi has been proven not to work" Believe what you want. Apparently baxter, allergan and lilly might have different views. You state you case as fact. Thats poor science by even elementary school standards. I see you as having a brilliant mind, but wasting it thru biased rationalization process. Thats how I see it. Just IMO.